Scientific content will cover basic cancer research and a variety of novel or emerging therapeutic approaches with sessions on cancer heterogeneity, genetics, epigenetics, molecular mechanisms, targeted therapies, immune therapies and translational/clinical research. Top-level leaders from both academia and industry will be attending.

The current confirmed speaker list includes James Downing, Matthew Walter, Louis Staudt, Seishi Ogawa, Jay Bradner, Chuan He, Stephen Nimer, Kristian Helin, Roel Nusse, Carl June, Margaret Goddell, Andreas Trumpp, Dominique Bonnet, George Demetri, Brian Druker, Suzanne Topalian, Mikael Dolsten, Kenneth Anderson, William Vainchenker, Lieping Chen and others.